A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster

OBJECTIVE(S): Tuberculosis affects one-third of the world’s population and leads to a high rate of morbidity and mortality. Bacillus Chalmette–Guerin (BCG) as the only approved vaccine for the Mycobacterium tuberculosis (Mtb) does not show enough protection in the vaccinated population. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Firouzi, Zohreh, Jaafari, Mahmoud Reza, Sankian, Mojtaba, Zare, Sirwan, Tafaghodi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124544/
https://www.ncbi.nlm.nih.gov/pubmed/35655599
http://dx.doi.org/10.22038/IJBMS.2022.61373.13583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124544/
https://www.ncbi.nlm.nih.gov/pubmed/35655599
http://dx.doi.org/10.22038/IJBMS.2022.61373.13583

Ejemplares similares